| NCT ID | NCT07122245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mansoura University Hospital |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-08-07 |
| Primary Completion | 2026-12-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-08-07 with a primary completion date of 2026-12-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.
Eligibility Criteria
Inclusion Criteria: * All female patients presented with bronchogenic carcinoma patients and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years. Exclusion Criteria: * lung metastasis ( not primary bronchogenic carcinoma)
Contact & Investigator
Mohamed AbdElmoniem
PRINCIPAL INVESTIGATOR
Lecturer of chest medicine faculty of medicine Mansoura university
Frequently Asked Questions
Who can join the NCT07122245 clinical trial?
This trial is open to female participants only, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07122245 currently recruiting?
Yes, NCT07122245 is actively recruiting participants. Contact the research team at dr.m1993@mans.edu.eg for enrollment information.
Where is the NCT07122245 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07122245 clinical trial?
NCT07122245 is sponsored by Mansoura University Hospital. The principal investigator is Mohamed AbdElmoniem at Lecturer of chest medicine faculty of medicine Mansoura university. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.